The large number of people with TRD has driven very high sales expectations for Spravato, with some analysts suggesting sales could reach around $2.3 billion within five years of launch.

Spravato has been approved since 2019 for TRD ... difficult-to-treat population and offers hope for the millions of people affected by TRD," he added. Analysts at GlobalData have previously ...

Spravato was first approved for use in 2019 to treat people with major depressive disorder who did not respond to at least two other antidepressants. Under that approval, patients had to take an ...

Educating people about the importance of mental health has been one of the best steps taken. Not so long ago, people did not believe in depression, let alone treat people who have depression ...

They can determine whether to prescribe Spravato. Doctors will likely not prescribe Spravato for people with certain blood vessel conditions. Examples include abdominal aortic aneurysm and ...

So Spravato is intranasal. BPL-003 is intranasal. Pretty well tolerated by a lot of people, but other folks just really don't like things being sprayed up in their nose. Oral thin films ...

41,366 people played the daily Crossword recently. Can you solve it faster than others?41,366 people played the daily Crossword recently. Can you solve it faster than others?

Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.

Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...